Yu Yuanyi, Deng Ting, Gu Shequn
Department of Gynecology, The First People's Hospital of Chenzhou, Hunan, China.
Department of Oncology, The First People's Hospital of Chenzhou, Hunan, China.
Int J Gynaecol Obstet. 2022 May;157(2):255-264. doi: 10.1002/ijgo.13796. Epub 2021 Jul 18.
To compare risk of recurrence and death related to minimally invasive surgery (MIS) and abdominal radical hysterectomy (ARH) in early-stage cervical cancer (CC) patients.
All relevant literatures in databases were retrieved from the built time of databases to October 2020. Observational studies comparing MIS and ARH in early-stage CC patients were involved. Newcastle-Ottawa Scale was used for quality assessment, including studies with a score of at least 6. Main outcomes involved overall survival (OS) and disease-free survival (DFS).
Twenty-two studies were involved, including 14 894 patients, among which 7213 (48.6%) underwent MIS. The OS (hazard ratio [HR] 1.23, 95% confidence interval [CI] 1.03-1.43) and DFS (HR 1.25, 95% CI 1.07-1.42) of patients undergoing MIS was obviously shortened compared with those of patients undergoing ARH. Subgroup analysis revealed that OS (HR 1.42, 95% CI 1.10-1.74) and DFS (HR 1.46, 95% CI 1.18-1.74) of patients with a tumor ≥2 cm in diameter were significantly reduced by MIS.
Overall survival and DFS after MIS for early-stage CC treatment were worse than those after ARH, especially for patients with a tumor ≥2 cm in diameter.
比较早期宫颈癌(CC)患者中,微创外科手术(MIS)和腹式广泛性子宫切除术(ARH)相关的复发风险和死亡风险。
检索数据库中自建库时间至2020年10月的所有相关文献。纳入比较早期CC患者中MIS和ARH的观察性研究。采用纽卡斯尔-渥太华量表进行质量评估,纳入得分至少为6分的研究。主要结局包括总生存期(OS)和无病生存期(DFS)。
共纳入22项研究,涉及14894例患者,其中7213例(48.6%)接受了MIS。与接受ARH的患者相比,接受MIS的患者OS(风险比[HR]1.23,95%置信区间[CI]1.03-1.43)和DFS(HR 1.25,95% CI 1.07-1.42)明显缩短。亚组分析显示,直径≥2 cm肿瘤患者接受MIS后,OS(HR 1.42,95% CI 1.10-1.74)和DFS(HR 1.46,95% CI 1.18-1.74)显著降低。
早期CC治疗中,MIS后的总生存期和DFS比ARH后的更差,尤其是对于直径≥2 cm肿瘤的患者。